So I was just watching an ad for Requip, a big-name drug for Restless Legs Syndrome. Restless Legs Syndrome, or “RLS,” as they’d like you to start calling it, is still highly disputed in terms of legitimacy, but the very vagueness of the symptoms and the difficulty of diagnosis make RLS a marketing director’s [...]